文献速递炎症性肠病消化内镜

小肠造影超声与横断面成像在克罗恩病小肠病变评估中的配对前瞻性验证研究

Correlation and Assessment of Small Bowel Lesions Using Cross-Sectional Imaging Techniques Compared With Small Intestinal Contrast Ultrasonography in Known Crohn's Disease (the CACTUS-CD Study): A Paired, Prospective, Confirmatory Study.
PubMed 文献 · Am J Gastroenterol · 2025-09-29

该配对前瞻性确证研究在高流量三级消化中心纳入407例需小肠评估的确诊克罗恩病患者,先进行肠道超声(IUS)后小肠造影超声(SICUS),并与24-48小时内完成的CTE或MRE对照。SICUS对疾病活动度的敏感度/特异度为95.3%/93.0%,对病变范围的敏感度/特异度为90.7%/90.5%,狭窄检出显著优于IUS(86.8% vs 71.3%,P=0.0005),但多数漏诊病变和狭窄位于近段/中段小肠。

要点

  • SICUS对CD活动度与范围诊断准确率高,可增强狭窄检出。
  • 近段/中段小肠病变及手术规划仍需CTE/MRE补充评估。
  • 横断面成像改变9.3%患者管理,支持超声优先策略。

核心结论

  • IUS是监测小肠CD的高准确无创工具,SICUS可提升狭窄检出。
  • CTE/MRE对近段和中段小肠病变及手术规划仍不可或缺。
  • 横断面成像总体增量影响有限,支持可扩展的超声优先路径。

研究设计与样本

  • 前瞻性、配对、确证性研究,在高流量三级消化中心开展。
  • 纳入18-75岁确诊CD且需小肠评估的患者407例,中位年龄36岁,男性60.2%。
  • 先行IUS后SICUS,并与24-48小时内CTE(n=215)或MRE(n=192)对照。

主要发现

  • SICUS诊断疾病活动度敏感度/特异度95.3%/93.0%,病变范围90.7%/90.5%。
  • SICUS狭窄检出率86.8%,显著高于IUS的71.3%(P=0.0005)。
  • SICUS对瘘管敏感度91.7%,对脓肿敏感度87.5%。
  • SICUS与CTE/MRE的肠壁厚度(R=0.667)和病变长度(R=0.839)强相关(P<0.001)。
  • 多数漏诊病变(n=17)和狭窄(n=22)位于近段/中段小肠;横断面成像改变9.3%(n=38)患者管理。

临床怎么用

  • 可将IUS作为小肠CD监测的首选无创工具,SICUS用于提高狭窄检出。
  • 对疑似近段/中段小肠病变或需手术规划者,应加做CTE/MRE。
  • 横断面成像改变管理的主要情形包括手术规划、升级治疗或狭窄干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Guidelines endorse intestinal ultrasound (IUS) for small bowel (SB) Crohn's disease (CD) monitoring but lack clarity on when to use magnetic resonance enterography (MRE) or computed tomography enterography (CTE). Small intestinal contrast ultrasound (SICUS) may improve detection, yet its added value-especially for proximal disease and treatment decisions-has not been prospectively validated against MRE/CTE in real-world settings. METHODS: This prospective study at a high-volume tertiary gastroenterology center recruited established patients with CD (18-75 years) requiring SB evaluation. The accuracy of IUS followed by SICUS was assessed against CTE/MRE (within 24-48 hours) for detecting activity, extent, bowel wall thickness, length, complications, and treatment impact. RESULTS: A total of 407 patients (median age 36 years; 60.2% male) underwent IUS/SICUS followed by CTE (n = 215) or MRE (n = 192). SICUS showed sensitivity/specificity of 95.3%/93.0% for disease activity and 90.7%/90.5% for extent. It significantly improved stricture detection over IUS (86.8% vs 71.3%, P = 0.0005), with sensitivity of 91.7% for fistulas and 87.5% for abscesses. SICUS correlated strongly with CTE/MRE for bowel wall thickness (Spearman rho, R = 0.667) and disease length ( R = 0.839) ( P < 0.001). Most missed lesions (n = 17) and strictures (n = 22) were in the proximal/mid-SB. Cross-sectional imaging changed management in 9.3% (n = 38), mainly for surgical planning, therapy escalation, or stricture intervention. DISCUSSION: IUS is a highly accurate, noninvasive tool for monitoring SB CD, with SICUS enhancing stricture detection. Although CTE/MRE remains essential for evaluating proximal and mid-SB disease and surgical planning, the limited overall incremental impact support a scalable, ultrasound-first approach (ClinicalTrials.gov: NCT06125678).

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Pal P, Mateen MA, Pooja K, et al. Correlation and Assessment of Small Bowel Lesions Using Cross-Sectional Imaging Techniques Compared With Small Intestinal Contrast Ultrasonography in Known Crohn's Disease (the CACTUS-CD Study): A Paired, Prospective, Confirmatory Study. Am J Gastroenterol. 2025. PMID: 41020653. doi:10.14309/ajg.0000000000003776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。